Press Release | Thu May 2, 2013 4:53pm EDT

FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face

* Reuters is not responsible for the content in this press release.